# Risk Analysis

## Overview

This document outlines the risk analysis for the Wound Segmentation AI system in accordance with ISO 14971 for medical device software.

## Hazard Identification

### Software Failures
| Hazard | Potential Harm | Severity | Mitigation |
|--------|---------------|----------|------------|
| False negative wound detection | Delayed treatment | High | Sensitivity monitoring, physician review threshold |
| False positive (normal tissue as wound) | Unnecessary treatment | Medium | Specificity targets, QC checks |
| Model degeneration over time | Degraded performance | High | Ongoing validation, drift detection |
| Data corruption | Incorrect segmentation | High | Checksums, input validation |

### Deployment Risks
| Risk | Mitigation |
|------|------------|
| Insufficient GPU memory | Model size limits, batch size caps |
| Network latency | Local inference option |
| Model version mismatch | Registry with validation |
| Unauthorized access | API authentication, audit logs |

## Control Measures

1. **Input Validation**: All images pass quality control before processing
2. **Threshold Safeguards**: Dice < 0.85 triggers physician review
3. **Audit Trail**: All predictions logged with timestamps
4. **Version Control**: Model registry tracks all production versions
5. **Graceful Degradation**: Clear error messages when service unavailable

## Post-Market Surveillance

- Monthly performance metrics review
- Quarterly physician agreement studies
- Annual model retraining on updated datasets
- Adverse event reporting procedure

## Severity Ratings

- **Critical**: Patient harm possible (e.g., missed wound detection)
- **Major**: Significant performance degradation
- **Minor**: Cosmetic or non-clinical issues
- **Negligible**: No clinical impact
